Multidimensional Impacts on Bryophyllum Pinnatum for the Potential of Obesity: A Review


Year : 2024 | Volume : 02 | Issue : 02 | Page : 42-51
    By

    Varun Mishra,

  • Sarbjot Singh,

  • Anuneet Kaur,

  • Rajneesh Kaur,

  • Brij Bhushan,

  • Anita Devi,

  • Shruti Jaswal,

  1. Student, Bachelor of Pharmacy (Final Year), Himachal Pharmacy College, Majhauli (Nalagarh), Himachal Pradesh, India
  2. Associate Professor, Department of Pharmacology, Himachal Pharmacy College, Majhauli (Nalagarh), Himachal Pradesh, India
  3. Assistant Professor, Department of Pharmacology, Himachal Pharmacy College, Majhauli (Nalagarh), Himachal Pradesh, India
  4. Associate Professor, Department of Pharmaceutical Chemistry, Himachal Pharmacy College, Majhauli (Nalagarh), Himachal Pradesh, India
  5. Associate Professor, Department of Pharmaceutical Chemistry, Himachal Pharmacy College, Majhauli (Nalagarh), Himachal Pradesh, India
  6. Assistant Professor, Department of Pharmaceutical Chemistry, Himachal Pharmacy College, Majhauli (Nalagarh), Himachal Pradesh, India
  7. Associate Professor, Department of Pharmaceutics, Himachal Pharmacy College, Majhauli (Nalagarh), Himachal Pradesh, India

Abstract

Global public health concerns related to obesity are growing. Several comorbid illnesses, including cardiovascular disease (CVC), gastrointestinal disorders, type 2 diabetes (T2d), joint and muscle disorders, respiratory difficulties, and psychological disorders, are significantly more common in obese patients. The widespread misconception that obesity stems solely from a lack of self-control is gradually losing its stigma as awareness about fat-related issues grows. Instead of synthetic drugs herbal or medicinal plants are much beneficial in the treatment of obesity. Bryophyllum pinnatum leaves have been employed as an antibiotic in traditional medicine. So, in this paper we reviewed that plant have various pharmacological effects on the body with very less side effects and their active phytoconstituents have an soothing effect to get rid of obesity.

Keywords: Obesity, synthetic drugs, medicinal plants, phytoconstituents, Bryophyllum Pinnatum

[This article belongs to International Journal of Biochemistry and Biomolecule Research (ijbbr)]

How to cite this article:
Varun Mishra, Sarbjot Singh, Anuneet Kaur, Rajneesh Kaur, Brij Bhushan, Anita Devi, Shruti Jaswal. Multidimensional Impacts on Bryophyllum Pinnatum for the Potential of Obesity: A Review. International Journal of Biochemistry and Biomolecule Research. 2024; 02(02):42-51.
How to cite this URL:
Varun Mishra, Sarbjot Singh, Anuneet Kaur, Rajneesh Kaur, Brij Bhushan, Anita Devi, Shruti Jaswal. Multidimensional Impacts on Bryophyllum Pinnatum for the Potential of Obesity: A Review. International Journal of Biochemistry and Biomolecule Research. 2024; 02(02):42-51. Available from: https://journals.stmjournals.com/ijbbr/article=2024/view=190718


Browse Figures

References

1. Fruh SM, Graves RJ, Hauff C, Williams SG, Hall HR. Weight bias and stigma: Impact on health. Nurs Clin North Am. 2021;56(4):479–493. doi: 10.1016/j.cnur.2021.07.001.
2. Nam GE, Kim YH, Han K, Jung JH, Rhee EJ, Lee WY. Obesity fact sheet in Korea, 2020: Prevalence of obesity by obesity class from 2009 to 2018. J Obes Metab Syndr. 2021;30(2):141. doi: 10.7570/jomes21056.
3. Seo MH, Lee WY, Kim SS, Kang JH, Kang JH, Kim KK, et al. 2018 Korean society for the study of obesity guideline for the management of obesity in Korea. J Obes Metab Syndr. 2019;28(1):40–45. doi: 10.7570/jomes.2019.28.1.40.
4. Telci Caklili O, Cesur M, Mikhailidis DP, Rizzo M. Novel anti-obesity therapies and their different effects and safety profiles: A critical overview.
Diabetes Metab Syndr Obes. 2023;16:1767–1774. doi: 10.2147/DMSO.S392684.
5. Kapoor N, Kalra S, Al Mahmeed W, Al-Rasadi K, Al-Alawi K, Banach M, et al. The dual pandemics of COVID-19 and obesity: Bidirectional impact. Diabetes Ther. 2022;13(10):1723–1736. doi: 10.1007/s13300-022-01311-2.
6. World Health Organization. Constitution of the world health organization.
7. Swinburn BA, Kraak VI, Allender S, Atkins VJ, Baker PI, Bogard JR, et al. The global syndemic of obesity, undernutrition, and climate change: The Lancet Commission report. Lancet. 2019;393(10173):791–846. doi: 10.1016/S0140-6736(18)32822-8.
8. Nihalani N, Schwartz TL, Siddiqui UA, Megna JL. Weight gain, obesity, and psychotropic prescribing. J Obes. 2011;2011(1):893629. doi: 10.1155/2011/893629.
9. Cappuccio FP, Taggart FM, Kandala NB, Currie A, Peile E, Stranges S, et al. Meta-analysis of short sleep duration and obesity in children and adults. Sleep. 2008;31(5):619–626. doi: 10.1093/sleep/31.5.619.
10. Noh J. The effect of circadian and sleep disruptions on obesity risk. J Obes Metab Syndr. 2018;27(2):78–83. doi: 10.7570/jomes.2018.27.2.78.
11. McAllister EJ, Dhurandhar NV, Keith SW, Aronne LJ, Barger J, Baskin M, et al. Ten putative contributors to the obesity epidemic. Crit Rev Food Sci Nutr. 2009;49(10):868–913. doi: 10.1080/10408390903372599.
12. Lim HJ, Xue H, Wang Y. Global trends in obesity. In: Handbook of Eating and Drinking: Interdisciplinary Perspectives. 2020:1217–1235.
13. Bray GA, Kim KK, Wilding JP, World Obesity Federation. Obesity: A chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Obes Rev. 2017;18(7):715–723. doi: 10.1111/obr.12551.
14. Burki T. European Commission classifies obesity as a chronic disease. Lancet Diabetes Endocrinol. 2021;9(7):418. doi: 10.1016/S2213-8587(21)00145-5.
15. Rubino F, Batterham RL, Koch M, Mingrone G, le Roux CW, Farooqi IS, et al. Lancet Diabetes & Endocrinology Commission on the definition and diagnosis of clinical obesity. Lancet Diabetes Endocrinol. 2023;11(4):226–228. doi: 10.1016/S2213-8587(23)00058-X.
16. Hall KD, Kahan S. Maintenance of lost weight and long-term management of obesity. Med Clin North Am. 2018;102(1):183–197. doi: 10.1016/j.mcna.2017.08.012.
17. Look AHEAD Research Group Wing RR, Bolin P, Brancati FL, Bray GA, Clark JM, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369(2):145–154. doi: 10.1056/NEJMoa1212914.
18. Elhayany A, Lustman A, Abel R, Attal‐Singer J, Vinker S. A low carbohydrate Mediterranean diet improves cardiovascular risk factors and diabetes control among overweight patients with type 2 diabetes mellitus: A 1‐year prospective randomized intervention study.
Diabetes Obes Metab. 2010;12(3):204–209. doi: 10.1111/j.1463-1326.2009.01151.x.
19. Harrington J, Felker GM, Januzzi JL, Lam CS, Lingvay I, Pagidipati NJ, et al. Worth their weight? An update on new and emerging pharmacologic agents for obesity and their potential role for persons with cardiac conditions. Current Cardiol Rep. 2024;26(3):61–71. doi: 10.1007/s11886-023-02016-z.
20. Green L, Taddei-Allen P. Shifting paradigms: Reframing coverage of antiobesity medications for plan sponsors. J Manag Care Spec Pharm. 2023;29(5):564–568. doi: 10.18553/jmcp.2023.29.5.564.
21. Gadde KM, Atkins KD. The limits and challenges of antiobesity pharmacotherapy. Expert Opin Pharmacother. 2020;21(11):1319–1328. doi: 10.1080/14656566.2020.1748599.
22. Li RY, Song HD, Shi WJ, Hu SM, Yang YS, Tang JF, et al. Galanin inhibits leptin expression and secretion in rat adipose tissue and 3T3-L1 adipocytes. J Mol Endocrinol. 2004;33(1):11–20. doi: 10.1677/jme.0.0330011.
23. Collaborators GB, Ärnlöv J. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1223–1249. doi: 10.1016/S0140-6736(20)30752-2.
24. Okunogbe A, Nugent R, Spencer G, Powis J, Ralston J, Wilding J. Economic impacts of overweight and obesity: Current and future estimates for 161 countries. BMJ Glob Health. 2022;7(9):e009773. doi: 10.1136/bmjgh-2022-009773.
25. Field AE, Coakley EH, Must A, Spadano JL, Laird N, Dietz WH, et al. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med. 2001;161(13):1581–1586. doi: 10.1001/archinte.161.13.1581.
26. Flier JS. Obesity wars: Molecular progress confronts an expanding epidemic. Cell. 2004;116(2):337–350. doi: 10.1016/s0092-8674(03)01081-x.
27. Moro CO, Basile G. Obesity and medicinal plants. Fitoterapia. 2000;71 Suppl 1:S73–S82. doi: 10.1016/s0367-326x(00)00177-5.
28. Lee JS, Lee MK, Ha TY, Bok SH, Park HM, Jeong KS, et al. Supplementation of whole persimmon leaf improves lipid profiles and suppresses body weight gain in rats fed high-fat diet. Food Chem Toxicol. 2006;44(11):1875–1883. doi: 10.1016/j.fct.2006.06.014.
29. Nagaratna A, Hegde PL. A comprehensive review on Parnabeeja [Bryophyllum pinnatum (Lam.) Oken]. J Med Plants Stud. 2015;3(5):166–171.
30. Beshir SA, Elnour AA, Soorya A, Mohamed AP, Goh SS, Hussain N, et al. A narrative review of approved and emerging anti-obesity medications. Saudi Pharm J. 2023;31(10):101757. doi: 10.1016/j.jsps.2023.101757.
31. Kishino E, Ito T, Fujita K, Kiuchi Y. A mixture of the Salacia retuculata (Kotalahimbutu) aqueous extract and cyclodextrin reduces the accumulation of visceral fat mass in mice and rats with high-fat diet induced obesity. J Nutr. 2006;136(2): 433–439. doi: 10.1093/jn/136.2.433.
32. Shrestha S, Bhattarai BR, Lee KH, Cho H. Mono-and disalicylic acid derivatives: PTP1B inhibitors as potential anti-obesity drugs. Bioorg Med Chem. 2007;15(20):6535–6548. doi: 10.1016/j.bmc.2007.07.010.
33. Barness LA, Opitz JM, Gilbert‐Barness E. Obesity: Genetic, molecular, and environmental aspects. Am J Med Genet A. 2007;143(24):3016–3034. doi: 10.1002/ajmg.a.32035.
34. Afzal M, Ahmad K, Saleem S, Kazmi I, Anwar F. Effect of Bryophyllum pinnatum Lam. on N-diethyl nitrosamine induced hepatic injury in rats. Biosci Biotechnol Res Asia. 2016;9(2). doi: 10.13005/bbra/1060.
35. Kamboj A, Saluja A. Bryophyllum pinnatum (Lam.) Kurz.: Phytochemical and pharmacological profile: A review. Pharmacognosy Reviews. 2009;3(6):364.
36. Pal S, Chaudhuri AN. Studies on the anti-ulcer activity of a Bryophyllum pinnatum leaf extract in experimental animals. J Ethnopharmacol. 1991;33(1–2):97–102. doi: 10.1016/0378-8741(91)90168-D.
37. Igwe SA, Akunyili DN. Analgesic effects of aqueous extracts of the leaves of Bryophyllum pinnatum. Pharma Biol. 2005;43(8):658–661. doi: 10.1080/13880200500383108.
38. Pal S, Sen T, Chaudhuri AK. Neuropsychopharmacological profile of the methanolic fraction of Bryophyllum pinnatum leaf extract. J Pharm Pharmacol. 1999;51(3):313–318. doi: 10.1211/0022357991772312.
39. Jaiswal S, Sawhney S. Correlation of epiphyllous bud differentiation with foliar senescence in crassulacean succulent Kalanchoe pinnata as revealed by thidiazuron and ethrel application. J Plant Physiol. 2006;163(7):717–722. doi: 10.1016/j.jplph.2005.08.001.
40. Akinpelu DA. Antimicrobial activity of Bryophyllum pinnatum leaves. Fitoterapia. 2000;71(2):193–194. doi: 10.1016/s0367-326x(99)00135-5.
41. Okwu DE, Nnamdi FU. Two novel flavonoids from Bryophyllum pinnatum and their antimicrobial activity. J Chem Pharm Res. 2011;3(2):1–10.
42. Aransiola EF, Daramola MO, Iwalewa EO, Seluwa AM, Olufowobi OO. Anti-diabetic effect of Bryophyllum pinnatum leaves. IJBB. 2014;8(1):89–93.
43. Khan M, Patil PA, Shobha JC. Influence of Bryophyllum pinnatum (Lim.) leaf extract on wound healing in albino rats. J Nat Remedies. 2004;4(1):41–46. doi: 10.18311/jnr/2004/380.
44. Gesta S, Tseng YH, Kahn CR. Developmental origin of fat: Tracking obesity to its source. Cell. 2007;131(2):242–256. doi: 10.1016/j.cell.2007.10.004.
45. Balistreri CR, Caruso C, Candore G. The role of adipose tissue and adipokines in obesity‐related inflammatory diseases. Mediators Inflamm. 2010;2010(1):802078. doi: 10.1155/2010/802078.
46. Patel PS, Buras ED, Balasubramanyam A. The role of the immune system in obesity and insulin resistance. J Obes. 2013;2013(1):616193. doi: 10.1155/2013/616193.
47. Kosteli A, Sugaru E, Haemmerle G, Martin JF, Lei J, Zechner R, et al. Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. J Clin Invest. 2010;120(10):3466–3479. doi: 10.1172/JCI42845.
48. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest. 1995;95(5):2409–2415. doi: 10.1172/JCI117936.
49. Tsigos C, Kyrou I, Chala E, Tsapogas P, Stavridis JC, Raptis SA, et al. Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity. Metabolism. 1999;48(10):1332–1335. doi: 10.1016/s0026-0495(99)90277-9.
50. Fernández-Sánchez A, Madrigal-Santillán E, Bautista M, Esquivel-Soto J, Morales-González Á, Esquivel-Chirino C, et al. Inflammation, oxidative stress, and obesity. Int J Mol Sci. 2011;12(5):3117–3132. doi: 10.3390/ijms12053117.
51. Gahlaut A, Pawar SD, Mandal TK, Dabur R. Evaluation of clinical efficacy of Bryophyllum pinnatum Salisb for treatment of lithiasis. Int J Pharm Pharm Sci. 2012;4(4):505–507.
52. Gupta R, Lohani M, Arora S. Anti-inflammatory activity of the leaf extracts/fractions of Bryophyllum pinnatum Saliv. Syn. Int J Pharm Sci Rev Res. 2010;3(1):16–18.
53. Mahata S, Maru S, Shukla S, Pandey A, Mugesh G, Das BC, et al. Anticancer property of Bryophyllum pinnata (Lam.) Oken. leaf on human cervical cancer cells. BMC Complement Altern Med. 2012;12:15. doi: 10.1186/1472-6882-12-15.
54. Bagul M, Srinivasa H, Anandjiwala S, Rajani M. Phytochemical evaluation and free radical scavenging activity of Nagakesara (stamen of Mesua ferrea Linn. var. ferrea). Indian Drugs. 2006;43(8):665–670.
55. Harlalka GV, Patil CR, Patil MR. Protective effect of Kalanchoe pinnata pers.(Crassulaceae) on gentamicin-induced nephrotoxicity in rats. Indian J Pharmacol. 2007;39(4):201–205. doi: 10.4103/0253-7613.36540.
56. Sreejayan, Rao MN. Nitric oxide scavenging by curcuminoids. J Pharm Pharmacol. 1997;49(1):105–107. doi: 10.1111/j.2042-7158.1997.tb06761.x.
57. Jain VC, Patel NMb, Shah DP, Patel PK, Joshi BH. Antioxidant and antimicrobial activities of Bryophyllum calycinum salisb leaf. Pharmacologyonline. 2010;1:393–405.
58. Muzitano MF, Tinoco LW, Guette C, Kaiser CR, Rossi-Bergmann B, Costa SS. The antileishmanial activity assessment of unusual flavonoids from Kalanchoe pinnata. Phytochemistry. 2006;67(18):2071–2077. doi: 10.1016/j.phytochem.2006.06.027.


Regular Issue Subscription Original Research
Volume 02
Issue 02
Received 12/11/2024
Accepted 21/11/2024
Published 24/12/2024


Loading citations...